Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review

Abstract

A systematic review was undertaken to examine all available evidence to develop and support clinical recommendations regarding the use of fulvestrant (Faslodex®) as systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women. MEDLINE, EMBASE, American Society of Clinical Oncology Annual Meeting proceedings, San Antonio Breast… (More)
DOI: 10.1007/s10549-008-0137-8

Topics

4 Figures and Tables

Cite this paper

@article{Flemming2008FulvestrantFS, title={Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review}, author={Jennifer A Flemming and Yolanda Madarnas and Jacob A. Franek}, journal={Breast Cancer Research and Treatment}, year={2008}, volume={115}, pages={255-268} }